Immuron Ltd (IMRN) Form 6-K — Nov 18, 2026
Immuron reported FY26 global sales revenue of AUD $7.7 million, up 6%, with net loss narrowing to AUD $(3.8) million and cash of AUD $9.0 million. FY27 year-to-date October revenue is up 10% globally, though U.S. sales are down 19% while Canada is up 150%. At the 2026 AGM, shareholders passed the remuneration report and re-elected Dr Jeannette Joughin, but rejected resolutions on increased placement capacity, the omnibus incentive plan, and a non-board-endorsed candidate.
Key figures
- Revenue
- AUD $7.7m FY26 global sales revenue
- Net Income
- AUD $(3.8)m net profit (improved $1.4m)
- Revenue Yoy
- Up 6%
- Cash Position
- AUD $9.0m
- Fy26 us revenue
- AUD $1.8m (up 7% USD)
- Fy26 gross margin
- 64.5% (0.9% decline)
- Fy26 australia revenue
- AUD $5.8m (up 10%)
- Fy27 ytd oct global revenue
- AUD $3.0m (up 10%)
- Fy27 ytd usa revenue change
- down 19%
- Imm529 peak sales estimate us
- US$400 million (Lumanity estimate)
- Fy27 ytd canada revenue change
- up 150%
- Remuneration report against vote
- 43.58%
- Placement capacity resolution failed
- 65.62% against
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.